D.M. Fisher
Department of Anesthesia
University of California
San Francisco 94143-0648
USA
Name/email consistency: high
- Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion. Fisher, D.M., Dempsey, G.A., Atherton, D.P., Brown, R., Abengochea, A., Hunter, J.M. Anesthesiology (2000)
- Factors affecting the pharmacokinetic characteristics of rapacuronium. Fisher, D.M., Kahwaji, R., Bevan, D., Bikhazi, G., Fragen, R.J., Angst, M.S., Ornstein, E., Matteo, R.S. Anesthesiology (1999)
- The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium. Fisher, D.M., Reynolds, K.S., Schmith, V.D., Hsu, J., Sokoll, M.D., Lennon, R.L., Caldwell, J.E. Anesth. Analg. (1999)
- Pharmacodynamic modeling of vecuronium-induced twitch depression. Rapid plasma-effect site equilibration explains faster onset at resistant laryngeal muscles than at the adductor pollicis. Fisher, D.M., Szenohradszky, J., Wright, P.M., Lau, M., Brown, R., Sharma, M. Anesthesiology (1997)
- Are plasma concentration values necessary for pharmacodynamic modeling of muscle relaxants?. Fisher, D.M., Wright, P.M. Anesthesiology (1997)
- Pharmacokinetics of rocuronium during the three stages of liver transplantation. Fisher, D.M., Ramsay, M.A., Hein, H.A., Marcel, R.J., Sharma, M., Ramsay, K.J., Miller, R.D. Anesthesiology (1997)
